- Previous Close
23.90 - Open
23.90 - Bid 23.70 x --
- Ask 23.95 x --
- Day's Range
23.40 - 24.10 - 52 Week Range
15.57 - 30.66 - Volume
1,891 - Avg. Volume
30,053 - Market Cap (intraday)
235.881M - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
-- - EPS (TTM)
-1.22 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 13, 2018
- 1y Target Est
40.10
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and reporting; DeepRhythmAI, a AI algorithms device for ECG analysis; and Virtual Cardiac Stress Test, a AI-based medical system for coronary artery atherosclerotic stenosis. The company is developing ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling one-channel offline monitoring; and NextGen, a software version for PocketECG. In addition, it offers information technology, ECG monitoring, and scientific research and development services; and manufactures electrical equipment for medicines. Medicalgorithmics S.A. company was incorporated in 2005 and is headquartered in Warsaw, Poland.
www.medicalgorithmics.plRecent News: MDG.WA
View MorePerformance Overview: MDG.WA
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDG.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDG.WA
View MoreValuation Measures
Market Cap
237.87M
Enterprise Value
227.30M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.75
Price/Book (mrq)
2.93
Enterprise Value/Revenue
7.41
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-39.53%
Return on Assets (ttm)
-6.77%
Return on Equity (ttm)
-13.85%
Revenue (ttm)
30.67M
Net Income Avi to Common (ttm)
-12.12M
Diluted EPS (ttm)
-1.22
Balance Sheet and Cash Flow
Total Cash (mrq)
6.27M
Total Debt/Equity (mrq)
4.76%
Levered Free Cash Flow (ttm)
-12.78M